American Shared Hospital Services (AMS) AI Stock Analysis

• Market Cap: $16.45M
• Dividend Yield: N/A
• Average Volume (3M): 13.97K
• Price to Earnings (P/E): 11.5
• Beta (1Y): 0.06
• Revenue Growth: 35.25%
• EPS Growth: 175.21%
• Country: US
• Employees: 81
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Care Facilities
• EPS (TTM): -0.10
• Shares Outstanding: 6,450,000
• 10 Day Avg. Volume: 5,212
• 30 Day Avg. Volume: 13,973
• PEG Ratio: -0.32
• Price to Book (P/B): 0.64
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -2.49
• Enterprise Value/Market Cap: 0.49
• Enterprise Value/Revenue: 0.08
• Enterprise Value/Gross Profit: 1.02
• Enterprise Value/Ebitda: 0.21
• 1Y Price Target: $3.00
• Price Target Upside: 23.46% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 69 Neutral
• Price Target: $3.00 ▲(23.46%Upside)

AMS's overall score reflects strong revenue growth and strategic expansion efforts, tempered by challenges in operational efficiency and cash flow management. The attractive P/E ratio suggests valuation strength, while the technical analysis indicates mixed momentum. Earnings call insights highlight growth potential but also underline financial hurdles.

American Shared Hospital Services Business Overview & Revenue Model

Company Description

American Shared Hospital Services leases radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. As of December 31, 2021, it had 115 operating Gamma Knife units located in the United States, as well as two in South America in Lima, Peru and Guayaquil, Ecuador. The company also operates one PBRT system. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

How the Company Makes Money

AMS generates revenue through long-term contracts with hospitals and medical centers, where it provides advanced medical equipment like the Gamma Knife on a lease or fee-per-use basis. The company enters into agreements with healthcare facilities to supply and maintain these high-cost technologies, often without the upfront capital expenditure required for purchasing such equipment. Revenue streams include leasing fees, service fees for equipment maintenance, and per-treatment fees. AMS also benefits from strategic partnerships with major equipment manufacturers and healthcare providers, enabling them to offer comprehensive services and equipment upgrades, which contribute significantly to its earnings.

American Shared Hospital Services Financial Statement Overview

Summary

The company shows strong revenue growth and a stable balance sheet with low leverage, though challenges remain with negative free cash flow and fluctuating equity. Continued focus on operational efficiency is needed.

Income Statement

American Shared Hospital Services shows a positive revenue growth trajectory, with TTM revenue increasing to $29.2M from $28.3M annually. Gross profit margins remain healthy, though there is a notable decrease to 27.1% TTM from 32.4% annually. Net profit margin is positive at 4.9% TTM, reflecting improved profitability from a challenging past. The company shows volatility in EBIT, with a negative margin at -10.3% TTM, indicating operational challenges. EBITDA remains strong, highlighting potential operational efficiency.

Balance Sheet

The balance sheet indicates a stable financial position with a debt-to-equity ratio of 0.15 TTM, which is relatively low and manageable. However, stockholder equity decreased substantially, leading to an inflated equity ratio calculation. Return on equity for TTM stands at 5.9%, showcasing moderate efficiency in generating profits from shareholders' investments. Overall, the company's leverage appears well-managed, though equity fluctuations could pose risks.

Cash Flow

Operating cash flow to net income ratio is strong at 3.1 TTM, which indicates efficient cash generation relative to net income. However, the free cash flow is negative, highlighting potential challenges in covering capital expenditures. The free cash flow to net income ratio is also negative, indicating that the company needs to improve its cash flow management to support growth and investment activities.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	28.34M	21.32M	19.75M	17.63M	17.84M
Gross Profit	9.19M	9.34M	8.38M	6.73M	4.47M
EBITDA	8.91M	6.97M	8.44M	6.97M	-1.14M
Net Income	2.19M	610.00K	1.33M	678.00K	-7.06M
Balance Sheet
Total Assets	60.20M	48.16M	43.96M	45.43M	43.65M
Cash, Cash Equivalents and Short-Term Investments	11.03M	13.69M	12.45M	8.26M	3.96M
Total Debt	23.23M	15.68M	14.31M	16.13M	14.40M
Total Liabilities	30.17M	21.88M	22.33M	21.19M	20.00M
Stockholders Equity	25.18B	22.62M	21.63M	24.24M	19.27M
Cash Flow
Free Cash Flow	-7.77M	-555.00K	6.85M	4.59M	9.29M
Operating Cash Flow	167.00K	5.72M	7.24M	6.27M	9.74M
Investing Cash Flow	-7.07M	-6.27M	-388.00K	-1.67M	-2.39M
Financing Cash Flow	4.41M	1.91M	-2.66M	-655.00K	-4.81M

American Shared Hospital Services Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2.43
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMS, the sentiment is Positive. The current price of 2.43 is below the 20-day moving average (MA) of 2.44, below the 50-day MA of 2.49, and below the 200-day MA of 2.90, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.25 is Neutral, neither overbought nor oversold. The STOCH value of 40.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AMS.

American Shared Hospital Services Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AMS	69 Neutral	$16.45M	11.53	6.16%	―	35.25%	175.21%
Sector *	52 Neutral	$7.47B	-0.04	-63.86%	2.34%	16.17%	0.25%
MODV	49 Neutral	$44.50M	―	-951.52%	―	-0.70%	-2.38%
SCNX	40 Underperform	$26.89M	―	-30.97%	―	-97.79%	86.73%
IXHL	39 Underperform	$31.86M	―	-201.88%	―	―	―
GOVX	34 Underperform	$17.36M	―	-616.17%	―	―	71.39%

American Shared Hospital Services Corporate Events

American Shared Hospital Services Appoints New CEO

On April 3, 2025, American Shared Hospital Services announced the appointment of Gary Delanois as the new Chief Executive Officer, succeeding Raymond Stachowiak, who will remain as Executive Chairman. The company reported strong financial results for 2024, with a 32.9% increase in revenue driven by strategic expansion and operational strength. The acquisition of radiation therapy centers and new facility openings have been pivotal in this growth. The company is transitioning from a leasing model to a direct provider of radiation therapy services, aiming for sustainable long-term growth through increased patient volumes and operational enhancements.